Analytical Services International — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Analytical Services International (ASI) is a long-established, UK-based contract service laboratory specializing in high-quality bioanalytical and toxicological testing. Its core business is providing essential analytical services across the diagnostics, forensic, and pharmaceutical development sectors, supported by significant technical expertise and accreditation. The company is positioned as a trusted partner for complex analytical needs, from supporting clinical trials for novel psychedelics to aiding criminal investigations and routine therapeutic drug monitoring. As part of the Analytical Expert Labs network, it combines deep scientific specialization with a stable, service-oriented business model.

Diagnostics

Technology Platform

Advanced mass spectrometry (LC-MS/MS, high-resolution MS) and a proprietary assay library of over 250 validated small molecule methods.

Opportunities

Growing clinical research into psychedelic and other novel small-molecule therapies creates demand for specialized bioanalytical method development and testing.

Expansion of forensic drug testing services for law enforcement represents a new, adjacent revenue stream within its core competency.

The push for personalized medicine and optimized drug dosing supports continued growth in the therapeutic drug monitoring market.

Risk Factors

Revenue dependence on public sector contracts for forensic and toxicology services, which are subject to budget cycles and political priorities.

Intense competition in the bioanalytical CRO market from larger global players and other specialized labs, potentially leading to pricing pressure.

Regulatory risk associated with maintaining critical ISO 17025 accreditation and GLP/GCP compliance, which is fundamental to its credibility and operations.

Competitive Landscape

ASI competes in fragmented but competitive markets. In clinical trial bioanalysis, it faces large global CROs (e.g., Labcorp, IQVIA, PPD) and specialized bioanalytical CROs. In forensic toxicology, competitors include other accredited public and private laboratories serving the UK justice system. For TDM, it competes with hospital in-house labs and large commercial reference laboratories. ASI's differentiation lies in its deep small-molecule expertise, niche focus on complex assays (e.g., psychedelics, insulin), expert interpretation services, and its academic affiliation.

More companies in Diagnostics & Precision Medicine →More companies in United Kingdom →